Woodline Partners LP Increases Stake in Adicet Bio, Inc. to 3.3%

Woodline Partners LP has filed a Schedule 13G/A for Adicet Bio, Inc. (ACET), reporting a beneficial ownership of 313,124 shares of Common Stock as of March 31, 2026. This position represents approximately 3.3% of the company's outstanding shares, based on 9,596,407 shares reported as of March 10, 2026. The filing indicates an increase from a previous ownership level of 0.0%. Woodline Partners LP, a Delaware limited partnership acting as an investment adviser, holds sole voting and dispositive power over these shares on behalf of the Woodline Master Fund LP. The filing is a routine amendment (Amendment No. 1) and includes a certification that the securities were acquired in the ordinary course of business without the intent to change or influence the control of the issuer. The principal business office for the reporting person is located in San Francisco, California.